Our medicines Our science Our stories
Contact us Careers

Americas

Argentina

 Spanish

Brazil

 Portuguese

Canada
English / French

Chile

 Spanish

Colombia

 Spanish

Mexico

 Spanish

Peru

 Spanish

United States

 English

Asia Pacific

Australia

 English

China

 Simplified Chinese

India

 English

Japan

 Japanese

Korea

 Korean

New Zealand

 English

Singapore

 English

Taiwan

 Traditional Chinese

Thailand
English / Thai

Europe

Austria

 German

Belgium
English / Dutch / French

Czech Republic

 Czech

Denmark

 Danish

Finland

 Finnish

France

 French

Germany

 German

Greece

 Greek

Hungary

 Hungarian

Ireland

 English

Italy

 Italian

Luxembourg

 English

Netherlands
English / Dutch

Norway

 Norwegian

Poland

 Polish

Portugal

 Portuguese

Romania

 Romanian

Spain

 Spanish

Sweden

 Swedish

Switzerland
German / French

United Kingdom

 English

Middle East

Israel

 Hebrew

Saudi Arabia
English / Arabic

Turkey

 Turkish

United Arab Emirates
English / Arabic

Other

Other Markets

 Distributor Markets
bmsUScqPageLucene
Our Medicines

Immunology patient resources

Our commitment to elevating patient care in immunology

At Bristol Myers Squibb, we are working to deliver meaningful solutions that address unmet needs in rheumatology, pulmonology, and dermatology. While there has been progress with medicines for immune-mediated diseases, people living with these conditions may not respond to available treatments. Many continue to endure chronic symptoms and disease progression that can take a toll on their daily life.

Our goal is to restore some of what immune-mediated diseases have taken away — empowering patients and their loved ones to take back their lives.

Immunology focus areas

Rheumatology

Building on more than 20 years of experience, at Bristol Myers Squibb we are following the science to tailor therapies to a person’s individual needs, improve outcomes and expand treatment options for rheumatic diseases such as rheumatoid arthritis (RA), psoriatic arthritis, lupus and Sjogren's disease. Through our ongoing research, educational resources and partnerships with the community, our goal is to provide new solutions that advance care, provide the potential for remission and, in some cases, "reset" the immune system to provide functional cures.

Our commitment to elevating patient care in immunology

Rheumatoid arthritis

Learn more about RA, its symptoms and its potential impact on patients. 

Psoriatic arthritis

Learn more about psoriatic arthritis, a chronic, immune-mediated disease that impacts the joints and skin. 

Juvenile idiopathic arthritis

Learn more about juvenile idiopathic arthritis and how the disease may impact patients.

Lupus

Learn more about lupus, its symptoms and its potential impact on patients.

Systemic lupus erythematosus

Learn more about systemic lupus erythematosus, a chronic immune-mediated disease that can affect almost any organ.

Sjögrens Disease

Learn more about Sjögrens Disease, its symptoms and its potential impact on patients. 

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.

Back to top

Dermatology

At Bristol Myers Squibb, we are advancing innovative solutions to address the pressing needs that continue to exist for people living with dermatologic immune-mediated diseases. Our pioneering research is leading to the potential for safe and effective new medicines.

We are committed to providing resources that help with disease management and support, pursuing new treatments for diseases like psoriasis and atopic dermatitis and exploring a broad range of serious dermatologic conditions in our early research.  

Patient experience of living with psoriasis

Learn about Royce Thomas' experience of living with psoriasis, as he speaks with Frida Dunger Johnsson, executive director of IFPA, and the importance of supporting the global community of individuals impacted by psoriatic disease.

Understanding key psoriasis outcome measures 

Bristol Myers Squibb is committed to educating patients and healthcare providers about psoriasis so that they can work together to determine a disease management plan.

 

Psoriasis around the world 

Hear from patients, advocates and healthcare providers from around the world on the burden of psoriasis and learn about the health disparities faced by patients of color.

Psoriasis

Learn more about psoriasis, a widely prevalent, chronic, systemic immune-mediated disease.

Psoriatic arthritis

Learn more about psoriatic arthritis, a chronic, immune-mediated disease that impacts the joints and skin.

Psoriasis treatment types

Learning more about different types of treatment options can help people work with their healthcare providers on the approach best suited to their needs.

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.

Back to top

Pulmonology

Bristol Myers Squibb is committed to applying expertise regarding the role of fibrosis in the development of several immune-mediated diseases to advance new treatments that go beyond symptom relief and address the underlying causes of disease.

Lysophosphatidic acid receptor 1 (LPA1) in pulmonary fibrosis

Learn more about Bristol Myers Squibb's commitment to developing new treatments for immune-mediated diseases with our research on the LPA1 receptor and its role in idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

Breathing new hope into pulmonary fibrosis research care

Learn more about Bristol Myers Squibb is developing new therapies targeting LPA₁ to treat pulmonary fibrosis. Their goal is to stop lung scarring and improve patient outcomes.

Back to top

About our clinical trials

Learn about clinical trials and search for a clinical trial that might be right for you or a loved one.